Navigation Links
Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results
Date:3/13/2008

>-- Raised $24.8 million in two successful public offerings

Strengthened Intellectual Property Portfolio:

-- Granted a U.S. patent for HPV fusions to treat patients with HPV-

related diseases

-- Granted a U.S. patent covering heat shock protein fusions to treat

anogenital warts

-- Won an important challenge to two U.S. patents; U.S. Patent and

Trademark Office reissued composition of matter and methods of use for

Company's CoVal(TM) fusions

-- Granted European patent covering CoVal(TM) fusion proteins to treat

influenza

Gregory M. McKee, President and Chief Executive Officer at Nventa commented on the year: "2007 was a year of significant events at Nventa. We are very pleased with the progress we made during the past year as we advanced new HspE7 (HspE7 + Poly-ICLC) into a Phase 1 clinical trial and completed the safety evaluation for three of the four cohorts in the trial. We anticipate completing the evaluation of the remaining cohort by the end of the second quarter of 2008, and are working diligently to design the Phase 2 clinical program, expected to begin shortly after this Phase 1 trial, to test new HspE7 in a larger population of patients with cervical dysplasia." Mr. McKee continued, "With the strength of our Directors, the addition of two new senior managers and the creation of a distinguished board of international experts, we look forward to building additional value for our shareholders through the continued advancement of new HspE7 for human papillomavirus (HPV)-related diseases."

Total Year 2007 and Fourth Quarter Financial Results:

All amounts, unless specified otherwise, are in Canadian dollars.

Nventa reported a net loss of $12,413,000, or $0.06 per share, for the year ended December 31, 2007, compared to a net loss of $10,067,000, or $0.12 per share, for the same period in 2006. The increase in net loss in 2007 from 2006 is principally re
'/>"/>

SOURCE Nventa Biopharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial
2. Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results
3. Nventa updates progress of cervical dysplasia trial with new HspE7
4. Nventas CEO to present at two upcoming investor conferences
5. Nventa announces publication of HspE7 data
6. Nventa Initiates HspE7 Phase 1 Cervical Dysplasia Trial
7. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
8. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
10. Keryx Biopharmaceuticals Announces Additions to Management Team
11. XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... (PRWEB) August 27, 2014 “We are ... technology vendors,” said Ven Thangaraj, CEO of Radiant Sage. ... that are taking the imaging corelab market to a ... corelabs and research organizations to efficiently and effectively manage ... the data to be analyzed and read by trained ...
(Date:8/27/2014)... -- Research and Markets  has announced the addition ... Industry Report 2014" report to their offering. ... Industry Report 2014 is a professional and in-depth study ... mass spectrometer industry. The report provides a ... and industry chain structure. The isotope ratio mass spectrometer ...
(Date:8/27/2014)... After the boom of the energy ... beverage craze is going to be the stress relief ... use Stress Relief energy pattern which can be applied ... a beverage, including minerals, herbs and liquids. Stress Relief ... power into rapid recovery and helping to adapt more ...
(Date:8/26/2014)... believe is the thinnest-possible semiconductor, a new class ... atoms thick. , The University of Washington researchers ... materials can be connected in an atomically seamless ... be the basis for next-generation flexible and transparent ... technologies. , "Heterojunctions are fundamental elements of electronic ...
Breaking Biology Technology:Radiant Sage Named to CIOReview List of 100 Most Promising Technology Companies 2Global Stable Isotope Ratio Mass Spectrometer Industry Report 2014 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 4Scientists craft atomically seamless, thinnest-possible semiconductor junctions 2
... . Most people value large chunks of gold ... gold at the smallest possible scale, because single gold atoms are ... atoms are placed on a surface they tend to ball up ... scientists now managed to fix single gold atoms on special sites ...
... May 30, 2012  Luminex Corporation (NASDAQ: LMNX ... Jefferies 2012 Global Healthcare Conference to be held June ... ) The investor presentation by Patrick J. ... 1:30 p.m. Eastern time on Wednesday, June 6, 2012.  The ...
... Inc. (Nasdaq: AUXL ) today announced that executive ... to be held June 4-7, 2012 at the Grand Hyatt ... and President, is scheduled to present an overview of the ... Monday, June 4, 2012. A breakout session will be held ...
Cached Biology Technology:The finest gold dust in the world 2Luminex Corporation to Present at Jefferies 2012 Global Healthcare Conference 2Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference 2Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference 3Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference 4
(Date:8/27/2014)... of the human genome was unveiled today in the ... comparison yet of how the genomes of the fruit ... appearing August 28 in in the journal Nature ... species, genomes is "read out," and how their DNA ... add billions of entries to a publicly available archive ...
(Date:8/27/2014)... be getting effective doses of the HIV drug maraviroc, ... dosing studies, completed before the drug was licensed in ... that is key to removing maraviroc from the body. ... of the protein including nearly half of African-Americans ... compared to those who lack the protein even when ...
(Date:8/27/2014)... SALT LAKE CITY, Aug. 27, 2014 University of ... in his native Turkey, has won that nation,s highest ... Medal of Science. , Sekercioglu is among five researchers ... Scientific and Technical Research Council of Turkey. Three researchers ... won the Special Award, which is equivalent to ...
Breaking Biology News(10 mins):Encyclopedia of how genomes function gets much bigger 2Encyclopedia of how genomes function gets much bigger 3Encyclopedia of how genomes function gets much bigger 4Dosage of HIV drug may be ineffective for half of African-Americans 2University of Utah biologist wins Turkey's top science prize 2
... levels of greenhouse gases, particularly carbon dioxide (CO2), ... fuels, deforestation, cultivation of grasslands, drainage of the ... shifts in climate patterns have led scientists to ... and to develop methods to evaluate how changes ...
... On Monday 4 February, Dennis J. Selkoe and five other ... Leuven. The promoters for this honorary doctorate VIB-KU Leuven ... Dennis J. Selkoe for his scientific insights, but also for ... and other conditions that cause severe damage in the brain. ...
... RayBiotech, Inc. announced today that it has executed ... Institute (BSHRI) of Sun City, Arizona.  Under the terms ... the biochemical analysis of disease markers in biological samples.  ... the characterization of key biomarkers for the study of ...
Cached Biology News:New protocol recommendations for measuring soil organic carbon sequestration 2New protocol recommendations for measuring soil organic carbon sequestration 3New protocol recommendations for measuring soil organic carbon sequestration 4Prevention is better than cure. Also for Alzheimer's disease! 2Prevention is better than cure. Also for Alzheimer's disease! 3Prevention is better than cure. Also for Alzheimer's disease! 4RayBiotech, Inc. Executes Neuroscience Biomarker Master Services Agreement with Banner Sun Health Research Institute 2RayBiotech, Inc. Executes Neuroscience Biomarker Master Services Agreement with Banner Sun Health Research Institute 3
... software for JASCO HPLC systems. , Integrated Instrument Control ... EZChrom Elite can ... JASCO HPLC systems. This provides a completely integrated system to control ... each run. , ...
... Gel loading solution, ... for non-denaturing polyacrylamide and ... nucleic acids and offers ... tracking dyes (bromphenol blue ...
Rabbit polyclonal to QKI...
... Introducing SilverSNAP Stain for Mass Spectrometry ... proteome, mass spectrometry (MS) has emerged as ... Silver staining of 2-D gels is now ... of procedures that leads ultimately to identification ...
Biology Products: